Brief: Surrozen Publishes Study In Translational Vision Science And Technology Demonstrating Promise Of Szn-413 In Preclinical Models Of Diabetic Retinopathy
26/09/2022 14:34
Sept 26 (Reuters) - Surrozen Inc SRZN.O :
* SURROZEN INC - SURROZEN PUBLISHES STUDY IN TRANSLATIONAL
VISION
SCIENCE AND TECHNOLOGY DEMONSTRATING PROMISE OF SZN-413 IN
PRECLINICAL MODELS OF DIABETIC RETINOPATHY
* SURROZEN INC - RESULTS HIGHLIGHT POTENTIAL NOVEL TREATMENT
FOR
DIABETIC AND OTHER RETINOPATHIES
Source text for Eikon: ID:nGNX73K4qx
Further company coverage: SRZN.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Surrozen
See all newsBrief: Surrozen Announces Closing Of Second Tranche Of March 2025 Private Placement For $95.1 Million
Surrozen, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Surrozen Q2 Operating Income USD -10.37 Million
Surrozen, Inc. expected to post a loss of $1.29 a share - Earnings Preview
Brief: Surrozen Q1 EPS USD -11.65